ID

35508

Description

The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02487992

Link

https://clinicaltrials.gov/show/NCT02487992

Keywords

Versions (1)
  1. 3/6/19 3/6/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

March 6, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Colorectal Neoplasms NCT02487992

English

Eligibility Colorectal Neoplasms NCT02487992

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients who can accept curative operations 18-70 years old
Description

Curative Surgery Acceptable | Age

Data type

boolean

Alias
UMLS CUI [1,1]
C1511562
UMLS CUI [1,2]
C1879533
UMLS CUI [2]
C0001779
histologically confirmed with colorectal cancer at stage ⅳ
Description

Colorectal Carcinoma TNM clinical staging

Data type

boolean

Alias
UMLS CUI [1,1]
C0009402
UMLS CUI [1,2]
C3258246
patients who can accept oral drugs;
Description

Oral medication Acceptable

Data type

boolean

Alias
UMLS CUI [1,1]
C0175795
UMLS CUI [1,2]
C1879533
eastern cooperative oncology group (ecog) performance status was 0 - 1.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
hemoglobin＜8.0 g/dl,white blood cell ＜3 x 10^9/l;platelet count ＜75 x 10^9/l; alanine aminotransferase, glutamic-oxalacetic transaminase, blood urine nitrogen and creatinine more than normal limits on 3.0 times
Description

Hemoglobin measurement | White Blood Cell Count procedure | Platelet Count measurement | Alanine aminotransferase increased | Aspartate aminotransferase increased | Blood urea increased | Serum creatinine raised

Data type

boolean

Alias
UMLS CUI [1]
C0518015
UMLS CUI [2]
C0023508
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0151905
UMLS CUI [5]
C0151904
UMLS CUI [6]
C0151539
UMLS CUI [7]
C0700225
known or suspected allergy to the investigational agent or any agent given in association with this trial
Description

Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Clinical Trial | Hypersensitivity Suspected Investigational New Drugs | Hypersensitivity Suspected Pharmaceutical Preparations Clinical Trial

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0008976
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0750491
UMLS CUI [3,3]
C0013230
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0750491
UMLS CUI [4,3]
C0013227
UMLS CUI [4,4]
C0008976
pregnant or lactating patients
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
known history of human immunodeficiency virus (hiv), hepatitis c virus (hcv) or treponemapallidun (tp) infection
Description

HIV Infection | Hepatitis C | Syphilis

Data type

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C0019196
UMLS CUI [3]
C0039128
patients who are suffering from serious autoimmune disease
Description

Autoimmune Disease Serious

Data type

boolean

Alias
UMLS CUI [1,1]
C0004364
UMLS CUI [1,2]
C0205404
patients who had used long time or are using immunosuppressant
Description

Immunosuppressive Agents

Data type

boolean

Alias
UMLS CUI [1]
C0021081
patients who had active infection
Description

Communicable Disease

Data type

boolean

Alias
UMLS CUI [1]
C0009450
patients who are suffering from serious organ dysfunction
Description

Organ dysfunction Serious

Data type

boolean

Alias
UMLS CUI [1,1]
C0349410
UMLS CUI [1,2]
C0205404
patients who are suffering from other cancer
Description

Cancer Other

Data type

boolean

Alias
UMLS CUI [1]
C1707251
other situations that the researchers considered unsuitable for this study.
Description

Social situation Inappropriate Clinical Trial

Data type

boolean

Alias
UMLS CUI [1,1]
C0748872
UMLS CUI [1,2]
C1548788
UMLS CUI [1,3]
C0008976
Back to the top of the page

Similar models

Eligibility Colorectal Neoplasms NCT02487992

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Curative Surgery Acceptable | Age
Item
patients who can accept curative operations 18-70 years old
boolean
C1511562 (UMLS CUI [1,1])
C1879533 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
Colorectal Carcinoma TNM clinical staging
Item
histologically confirmed with colorectal cancer at stage ⅳ
boolean
C0009402 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Oral medication Acceptable
Item
patients who can accept oral drugs;
boolean
C0175795 (UMLS CUI [1,1])
C1879533 (UMLS CUI [1,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status was 0 - 1.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hemoglobin measurement | White Blood Cell Count procedure | Platelet Count measurement | Alanine aminotransferase increased | Aspartate aminotransferase increased | Blood urea increased | Serum creatinine raised
Item
hemoglobin＜8.0 g/dl,white blood cell ＜3 x 10^9/l;platelet count ＜75 x 10^9/l; alanine aminotransferase, glutamic-oxalacetic transaminase, blood urine nitrogen and creatinine more than normal limits on 3.0 times
boolean
C0518015 (UMLS CUI [1])
C0023508 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0151905 (UMLS CUI [4])
C0151904 (UMLS CUI [5])
C0151539 (UMLS CUI [6])
C0700225 (UMLS CUI [7])
Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Clinical Trial | Hypersensitivity Suspected Investigational New Drugs | Hypersensitivity Suspected Pharmaceutical Preparations Clinical Trial
Item
known or suspected allergy to the investigational agent or any agent given in association with this trial
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0750491 (UMLS CUI [3,2])
C0013230 (UMLS CUI [3,3])
C0020517 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C0013227 (UMLS CUI [4,3])
C0008976 (UMLS CUI [4,4])
Pregnancy | Breast Feeding
Item
pregnant or lactating patients
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV Infection | Hepatitis C | Syphilis
Item
known history of human immunodeficiency virus (hiv), hepatitis c virus (hcv) or treponemapallidun (tp) infection
boolean
C0019693 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0039128 (UMLS CUI [3])
Autoimmune Disease Serious
Item
patients who are suffering from serious autoimmune disease
boolean
C0004364 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Immunosuppressive Agents
Item
patients who had used long time or are using immunosuppressant
boolean
C0021081 (UMLS CUI [1])
Communicable Disease
Item
patients who had active infection
boolean
C0009450 (UMLS CUI [1])
Organ dysfunction Serious
Item
patients who are suffering from serious organ dysfunction
boolean
C0349410 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Cancer Other
Item
patients who are suffering from other cancer
boolean
C1707251 (UMLS CUI [1])
Social situation Inappropriate Clinical Trial
Item
other situations that the researchers considered unsuitable for this study.
boolean
C0748872 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial